What We Do

Biosyntax provides strategic counsel with these objectives:

• To make clear the value that life-sciences companies can deliver to both society and their investors, the life-enhancing potential of biomedical research, and the needs of patients;
• To explicate the promise of emerging technologies and new products;
• To shape well-reasoned positions on public-policy issues;
• To enlist the commitment of employees;
• To manage crises and corporate change.

With this strategic counsel, Biosyntax also brings the urgent intent of reaching a clear and actionable plan and then getting on with the day-to-day work. Action without intention is futile, to be sure, but so is brainstorming and strategizing without end. Sound thinking leads to doing, and Biosyntax brings experience to doing all of the following:

• Dealing directly with journalists, securities analysts, medical professionals, and patient advocates;
• Writing press releases, product and science backgrounders, annual reports, and executive speeches;
• Developing presentations to investors;
• Training executives in how to meet the press;
• Managing investor conferences, press conferences, and media relations at regulatory meetings;
• Producing videos and creating Web sites and print publications.